Sanofi seeks 22.8b euro deal in asset talks with Boehringer
Geneva
SANOFI is in exclusive talks to swap assets with Germany's Boehringer Ingelheim GmbH in a 22.8 billion-euro (S$35 billion) transaction that would be the largest for the French drugmaker in more than a decade.
Sanofi's animal-health business, valued at 11.4 billion euros, and Boehringer Ingelheim's consumer-health operations, at 6.7 billion euros, would be traded, according to a statement on Tuesday. Closely held Boehringer Ingelheim would also pay Sanofi 4.7 billion euros in cash.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Olam tops Louis Dreyfus’ offer for Australia’s Namoi Cotton as takeover battle heats up
Puma returns to sales growth in Americas despite ‘volatile’ market
Nanjing Xinjiekou Department Store announces May 23 EGM; Cordlife seeking legal advice
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
‘Limits’ to MOH intervention for Cordlife customer refunds, compensation: Janil
UG Healthcare fully acquires German associate company for 16.9 million euros